Tracey Hurrell

769 total citations
19 papers, 463 citations indexed

About

Tracey Hurrell is a scholar working on Molecular Biology, Hepatology and Biomedical Engineering. According to data from OpenAlex, Tracey Hurrell has authored 19 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Hepatology and 6 papers in Biomedical Engineering. Recurrent topics in Tracey Hurrell's work include Liver physiology and pathology (6 papers), 3D Printing in Biomedical Research (5 papers) and Pluripotent Stem Cells Research (4 papers). Tracey Hurrell is often cited by papers focused on Liver physiology and pathology (6 papers), 3D Printing in Biomedical Research (5 papers) and Pluripotent Stem Cells Research (4 papers). Tracey Hurrell collaborates with scholars based in South Africa, United Kingdom and Sweden. Tracey Hurrell's co-authors include Kathryn S. Lilley, Duncan Cromarty, Delilah Hendriks, Lisa M. Breckels, Andy Christoforou, Claire M. Mulvey, Magnus Ingelman‐Sundberg, Aikaterini Geladaki, Laurent Gatto and Penelope Hayward and has published in prestigious journals such as Nature Communications, Scientific Reports and Toxicological Sciences.

In The Last Decade

Tracey Hurrell

18 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracey Hurrell South Africa	10	220	130	128	99	68	19	463
Yan Xue China	12	217 1.0×	28 0.2×	57 0.4×	104 1.1×	13 0.2×	25	393
Rani Kunjithapatham United States	12	407 1.9×	53 0.4×	56 0.4×	19 0.2×	34 0.5×	16	616
Brian D. Follstad United States	10	542 2.5×	44 0.3×	95 0.7×	16 0.2×	21 0.3×	14	637
Valérie Haurie France	9	505 2.3×	28 0.2×	44 0.3×	13 0.1×	65 1.0×	10	613
Nina Senutovitch United States	6	123 0.6×	122 0.9×	272 2.1×	4 0.0×	20 0.3×	6	455
Bojing Zhu China	12	395 1.8×	12 0.1×	19 0.1×	117 1.2×	33 0.5×	26	541
Lindsey Maccoux Germany	10	230 1.0×	21 0.2×	110 0.9×	8 0.1×	15 0.2×	11	473
Christopher Storck United States	8	241 1.1×	110 0.8×	88 0.7×	3 0.0×	18 0.3×	12	349
Bochen Zhu China	8	261 1.2×	58 0.4×	25 0.2×	10 0.1×	9 0.1×	15	441
Tongying Shun United States	8	139 0.6×	41 0.3×	151 1.2×	4 0.0×	17 0.3×	10	366

Countries citing papers authored by Tracey Hurrell

Since Specialization

Citations

This map shows the geographic impact of Tracey Hurrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracey Hurrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracey Hurrell more than expected).

Fields of papers citing papers by Tracey Hurrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracey Hurrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracey Hurrell. The network helps show where Tracey Hurrell may publish in the future.

Co-authorship network of co-authors of Tracey Hurrell

This figure shows the co-authorship network connecting the top 25 collaborators of Tracey Hurrell. A scholar is included among the top collaborators of Tracey Hurrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracey Hurrell. Tracey Hurrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hurrell, Tracey, Mubeen Goolam, Chrisna Gouws, et al.. (2025). A new dawn: Vitalising translational oncology research in Africa with the help of advanced cell culture models. Translational Oncology. 56. 102391–102391.

Hurrell, Tracey, et al.. (2024). An African perspective on genetically diverse human induced pluripotent stem cell lines. Nature Communications. 15(1). 8581–8581. 4 indexed citations

Hurrell, Tracey, et al.. (2024). The Case for Pre-Emptive Pharmacogenetic Screening in South Africa. Journal of Personalized Medicine. 14(1). 114–114. 6 indexed citations

Hurrell, Tracey, et al.. (2024). The generation of human induced pluripotent stem cell lines from individuals of Black African ancestry in South Africa. Stem Cell Research. 81. 103534–103534. 5 indexed citations

Masimirembwa, Collen, Michèle Ramsay, Jean Botha, et al.. (2023). The African Liver Tissue Biorepository Consortium: Capacitating Population-Appropriate Drug Metabolism, Pharmacokinetics, and Pharmacogenetics Research in Drug Discovery and Development. Drug Metabolism and Disposition. 51(12). 1551–1560. 2 indexed citations

Hurrell, Tracey, et al.. (2022). Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance. Frontiers in Genetics. 13. 864725–864725. 2 indexed citations

Hurrell, Tracey, et al.. (2022). IPSC-derived models in Africa: An HIV perspective. Biochimie. 196. 153–160. 1 indexed citations

Mulvey, Claire M., Lisa M. Breckels, Oliver M. Crook, et al.. (2021). Spatiotemporal proteomic profiling of the pro-inflammatory response to lipopolysaccharide in the THP-1 human leukaemia cell line. Nature Communications. 12(1). 5773–5773. 36 indexed citations

Bout, Iman van den, et al.. (2021). Continual proteomic divergence of HepG2 cells as a consequence of long-term spheroid culture. Scientific Reports. 11(1). 10917–10917. 11 indexed citations

10.

Hurrell, Tracey, Delilah Hendriks, Åsa Nordling, et al.. (2020). Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis. Cells. 9(4). 964–964. 56 indexed citations

11.

Hurrell, Tracey, Charis‐Patricia Segeritz, Ludovic Vallier, Kathryn S. Lilley, & Duncan Cromarty. (2019). A proteomic time course through the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. Scientific Reports. 9(1). 3270–3270. 15 indexed citations

12.

Hendriks, Delilah, et al.. (2019). Mechanisms of Chronic Fialuridine Hepatotoxicity as Revealed in Primary Human Hepatocyte Spheroids. Toxicological Sciences. 171(2). 385–395. 23 indexed citations

13.

Baze, Audrey, C. Parmentier, Delilah Hendriks, et al.. (2018). Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells. Tissue Engineering Part C Methods. 24(9). 534–545. 70 indexed citations

14.

Hurrell, Tracey, et al.. (2018). Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro. Toxicology in Vitro. 50. 86–94. 35 indexed citations

15.

Hurrell, Tracey, Kathryn S. Lilley, & Duncan Cromarty. (2018). Proteomic responses of HepG2 cell monolayers and 3D spheroids to selected hepatotoxins. Toxicology Letters. 300. 40–50. 25 indexed citations

16.

Hurrell, Tracey, Charis‐Patricia Segeritz, Ludovic Vallier, Kathryn S. Lilley, & Duncan Cromarty. (2018). Proteomic Comparison of Various Hepatic Cell Cultures for Preclinical Safety Pharmacology. Toxicological Sciences. 164(1). 229–239. 4 indexed citations

17.

Christoforou, Andy, Claire M. Mulvey, Lisa M. Breckels, et al.. (2016). A draft map of the mouse pluripotent stem cell spatial proteome. Nature Communications. 7(1). 8992–8992. 157 indexed citations

18.

Hurrell, Tracey, et al.. (2013). Human epidermal growth factor receptor 2-positive breast cancer: which cytotoxic agent best complements trastuzumab's efficacy in vitro?. OncoTargets and Therapy. 6. 693–693. 1 indexed citations

19.

Hurrell, Tracey, et al.. (2013). The in vitro influences of epidermal growth factor and heregulin-β1 on the efficacy of trastuzumab used in Her-2 positive breast adenocarcinoma. Cancer Cell International. 13(1). 97–97. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact